why a multi-country study? why not conduct the whole thing in Rwanda? malaria is the same regardless.
Waiting for ethics approval in other countries may be a long time coming.
Good update though. Clear. No ambiguities as in most of Dermy's announcements.
Getting ready for the issue of another 100 million shares no doubt!!
why a multi-country study? why not conduct the whole thing in...
Add EMS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.6¢ |
Change
-0.002(11.1%) |
Mkt cap ! $1.818M | |||
| Open | High | Low | Value | Volume |
| 1.7¢ | 1.7¢ | 1.5¢ | $13.27K | 832.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 490533 | 1.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.6¢ | 213000 | 1 |
View Market Depth
| Last trade - 13.47pm 14/11/2024 (20 minute delay) ? |
| EMS (ASX) Chart |